Announce Date | 05/15/2025 |
EPS Normalized Actual | $-0.1 (Beat by $0.015) |
EPS GAAP Actual | $-0.1 (Beat by $0.015) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.1 |
EPS GAAP Estimate | $-0.1 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 2 |
Dec 2028 | -0.02 | -258.5 | -0.02 | -0.02 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0.0875 | 0B | NAN% | 0M |
FQ3 2024 (Sep 2024) | -0.13 | -0.0525 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.12 | -0.0425 | 0B | NAN% | 0M |
FQ3 2021 (Sep 2021) | -0.12 | -0.12 | 0B | NAN% | 0M |
FQ4 2021 (Dec 2021) | -0.18 | -0.18 | 0B | NAN% | 0M |
FQ1 2022 (Mar 2022) | -0.15 | -0.15 | 0B | NAN% | 0M |
FQ2 2022 (Jun 2022) | -0.13 | -0.13 | 0B | NAN% | 0M |
FQ3 2022 (Sep 2022) | -0.11 | -0.11 | 0B | NAN% | 0M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.1
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.0173 | -- | -0.0173 | -0.0173 | 1 |
FQ2 2027 (Jun 2027) | -0.0151 | -- | -0.0151 | -0.0151 | 1 |
FQ1 2027 (Mar 2027) | -0.031 | -- | -0.031 | -0.031 | 1 |
FQ4 2026 (Dec 2026) | -0.0373 | -- | -0.0373 | -0.0373 | 0 |
FQ3 2026 (Sep 2026) | -0.0279 | -- | -0.0279 | -0.0279 | 0 |
FQ2 2026 (Jun 2026) | -0.0277 | -- | -0.0277 | -0.0277 | 0 |
FQ1 2026 (Mar 2026) | -0.0381 | -- | -0.0381 | -0.0381 | 0 |
FQ4 2025 (Dec 2025) | -0.10602 | -- | -0.10602 | -0.10602 | 0 |
FQ3 2025 (Sep 2025) | -0.1 | -30 | -0.1 | -0.1 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 0 |
FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 0 |
FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
FQ4 2025 (Dec 2025) | 0B | -- | 0B | 0B | 0 |
FQ3 2025 (Sep 2025) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.0875 | 0 | 0.0875 | INF% |
FQ3 2024 (Sep 2024) | -0.0775 | -0.13 | -0.0525 | 40.38% |
FQ2 2024 (Jun 2024) | -0.0775 | -0.12 | -0.0425 | 35.42% |
FQ3 2021 (Sep 2021) | -0.12 | -0.12 | 100% | |
FQ4 2021 (Dec 2021) | -0.18 | -0.18 | 100% | |
FQ1 2022 (Mar 2022) | -0.15 | -0.15 | 100% | |
FQ2 2022 (Jun 2022) | -0.13 | -0.13 | 100% | |
FQ3 2022 (Sep 2022) | -0.11 | -0.11 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |
FQ2 2022 (Jun 2022) | $0B | $0B | $0M | NAN% |
FQ3 2022 (Sep 2022) | $0B | $0B | $0M | NAN% |